CORDIS
EU research results

CORDIS

English EN
Single Cell Technologies for SMEs

Single Cell Technologies for SMEs

Objective

This project is focused on development of technologies for separation and manipulation of single biological cells for life science research and medical applications. The research plan is built upon the results of the FP7 project PASCA (GA 257073, started 01.09.2010). The single cell manipulation technology (SCM technology) developed there is based on inkjet-like printing of single biological cells confined in free flying micro droplets. It constitutes a universal platform for single cell analysis that has been proven to have high potential for many life science applications. The objective of this project is to support the participating SMEs and companies to take up the SCM technology, to realize their own applications and to develop them into innovative products for the medical, biomedical and pharmaceutical markets. Central element of the research is the SCM prototype instrument as presented in numerous publications (see www.pasca.eu). The actual project will provide validation and extension of the use of this prototype instrument and deal with necessary improvements and modifications of pre-production prototypes towards the specific needs and applications of the SME partners. In particular also topics affecting commercial exploitation like e.g. application development, design for manufacturability, reliability issues, cost and throughput optimization, extension of technical specifications, and preparation of CE IVD labeling will be investigated. Applications targeted by the individual SMEs are considering fast pathogen detection for clinical use by combining the SCM technology with MALDI TOF mass spectroscopy of single bacteria, instruments for single cell cancer and stem cell research, methods for monoclonal cell line development and in-vitro medical diagnostic applications. The anticipated innovations stemming from this research will be exploited by the involved SMEs individually as well as jointly through several innovative products targeted for different markets and applications.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

BIOFLUIDIX GMBH

Address

George Koehler Allee 106 106
79110 Freiburg Im Breisgau

Germany

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU Contribution

€ 238 000

Administrative Contact

Wolfgang Streule (Dr.)

Participants (6)

Sort alphabetically

Sort by EU Contribution

Expand all

BIOSPARQ BV

Netherlands

EU Contribution

€ 273 750

Primadiag SAS

France

EU Contribution

€ 315 000

Innovative Technologies in Biological Systems

Spain

EU Contribution

€ 93 000

SOPHION BIOSCIENCE A/S

Denmark

EU Contribution

€ 107 250

ALBERT-LUDWIGS-UNIVERSITAET FREIBURG

Germany

EU Contribution

€ 6 000

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM

Netherlands

EU Contribution

€ 6 000

Project information

Grant agreement ID: 606167

Status

Closed project

  • Start date

    1 October 2013

  • End date

    30 September 2015

Funded under:

FP7-SME

  • Overall budget:

    € 1 400 224

  • EU contribution

    € 1 039 000

Coordinated by:

BIOFLUIDIX GMBH

Germany